Co-Diagnostics, Inc. JV CoSara Receives Clearance From Indian Regulators For High-Risk HPV Multiplex Test
Co-Diagnostics, Inc.(NASDAQ: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint venture for manufacturing and sales in India, has received clearance by the C